Clinical symptoms and pathophysiology of migraine;Kliniske symptomer og patofysiologi ved migræne

Ugeskrift for Laeger

Volumn 170, Issue 41, 2008, Pages 3231-3234

  Tfelt Hansen, Peer ^a,b   Ashina, Messoud ^a   Olesen, Jes ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; HUMAN; METABOLISM; MIGRAINE; MIGRAINE WITH AURA; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTISCANNING; VASCULARIZATION;

BRAIN; HUMANS; MIGRAINE DISORDERS; MIGRAINE WITH AURA; POSITRON-EMISSION TOMOGRAPHY;

EID: 54449091042     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Olesen J. Some clinical features of the acute migraine attack. An analysis of 750 patients. Headache 1978;18:268-71.
2. Olesen J, Goadsby PJ, Ramadan N et al eds. The Headaches. Third Edition. Philadelphia, Lippincott, Williams and Wilkins 2006:1-1169.
3. Detsky ME, McDonald DR, Baerlocher MO et al. Does this patient with headache have a migraine or need neuroimaging? JAMA 2006;296:1274-83.
4. Schoonman GG, Evers DJ, Terwindt GM et al. The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients. Cephalalgia 2006;26:1209-13.
5. Wolff HG. Headache and Other Head Pain. New York: Oxford University Press, 1963.
6. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-52.
7. Littlewood JT, Gibb C, Glover V et al. Red wine as a cause of migraine. Lancet 1988;1(8585):558-9.
8. Marcus DA, Scharff L, Turk D et al. A double-blind provocative study of chocolate as a trigger of headache. Cephalalgia 1997;17:655-62.
9. Moffett A, Swash M, Scott DF. Effect of tyramine in migraine: a double-blind study. J Neurol Neurosurg Psychiatry 1972;35:496-9.
10. Giffin NJ, Ruggiero L, Lipton RB et al. Premonitory symptoms in migraine: an electronic dairy study. Neurology 2003;60:935-40.
11. Argiolas A, Melis MR. The neuropharmacology of yawning. Eur J Pharmacol 1998;343:1-16.
12. Goesler UR, Hein G, Sadick H et al. Physiology, role and neuropharmacology of yawning. Laryngorhinootologie 2005;84:345-51.
13. Collins GT, Witkin JM, Newman AH et al. Dopamine agonist-induced yawning in rats: a do pamine D3 receptor mediated behaviour. J Pharmacol Exp Ther 2005;314:310-19.
14. Afridi SK, Kaube H, Goadsby PJ. Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain 2004;110:675-80.
15. Fabricius M, Fuhr S, Bhatia R et al. Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. Brain 2006;129:778-90.
16. Russel MB, Genetic epidemiology of migraine and cluster headache. Cephalalgia 1997;17:683-701.
17. Olesen J, Diener HC, Schoenen J et al. No effect of eletriptan administration during the auraphase of migraine. Eur J Neurol 2004;11:671-7.
18. Geraud G, Denuelle M, Fabre N et al. Positron emission tomographic studies of migraine. Rev Neurol (Paris) 2005;161:666-70.
19. Afridi S, Matharu MS, Lee L et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 2005;128:932-9.
20. Weiller C, May A, Limroth V et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995;1:658-60.
21. Iversen HK, Nielsen TH, Olesen J et al. Arterial responses during migraine headaches. Lancet 1990;336:837-9.
22. Drummond PD, Lance JW. Extracranial vascular changes and the source of pain in migraine headache. Ann Neurol 1983;13:32-7.
23. Jensen K. Extracranial blood flow, pain and tenderness in migraine. Clinical and experimental studies. Acta Neurol Scand Suppl 1993;147:1-27.
24. Hansen JM, Sitarz J, Birk S et al. Vasoactive intestinal peptide evokes only a minimal headache in hrealthy volunteers. Cephalalgia 2006;26:992-1003.
25. Friberg L, Olesen J, Iversen HK et al. Migraine pain associated with middle cerebral artery dilatation reversal by sumatriptan. Lancet 1991;338:13-7.
26. Tvedskov JF, Lipka K, Ashina M et al. No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 2005;58:561-8.
27. Olesen J, Diener H-C, Husstedt IW et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Eng J Med 2004;350: 1104-10.
28. Cerbo R, Barbanti P, Buzzi MG et al. Dopamine hypersensitivity in migraine: role of the apomorphine test. Clin Neuropharmacol 1997;20:36-41.
29. Blin O, Azula J, Masson G et al. Apomorphine-induced yawning in migraine patients: enhanced responsiveness. Clin Pharmacol 1991;14:91-5.
30. Honkaniemi J, Liimatainen S, Rainesalo S et al. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study. Headache 2006;46:781-7.
31. Kelman L, Tanis D. The relationship between migraine pain and other associated symptoms. Cephalalgia 2006;26:548-53.
32. Lampl C, Voelker M, Diener HC. Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompaning symptoms. J Neurol 207;254:705-12.
33. Vanagaite J, Pareja JA, Støren O et al. Light-inuced discomfort and pain. Cephalalgia 1997;17:733-41.
34. Vingen JV. Pareja JA, Støren O et al. Phonophobia in migraine. Cephalalgia 1998;18:243-9.
35. Zanchin G, Dainese F, Mainardi F et al. Osmophobia in primary headaches. J Headache Pain 2005;6:213-5.
36. Barbanti P, Fabbrini G, Pesare M et al. Unilateral cranial autonomic symptoms in migraine. Cephalalgia 2002;22:256-9.
37. Burstein R, Cutrer MF, Yamitsky D. The development of cutaneous allodynia during migraine attack.Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000;123:1703-9.
38. Kelman L. The postdrome of the acute migraine attack, Cephalalgia 2006;25:214-20.
39. Hargreaves R. New migraine and pain research. Headache 2007;47(Suppl 1):S26-S43.